ArticlePloS one2022

Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia.

Dominique F Leitner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.